113 related articles for article (PubMed ID: 10640836)
1. Receptor tyrosine kinase and p16/CDKN2 expression in a case of tripe palms associated with non-small-cell lung cancer.
Krähn G; Greulich KM; Bezold G; Dieterle C; Wolff H; Peter RU
Dermatology; 1999; 199(4):290-5. PubMed ID: 10640836
[TBL] [Abstract][Full Text] [Related]
2. Tripe palms: a cutaneous paraneoplastic syndrome.
Mullans EA; Cohen PR
South Med J; 1996 Jun; 89(6):626-7. PubMed ID: 8638207
[TBL] [Abstract][Full Text] [Related]
3. [Tripe palms and a hypertrophic osteoarthropathy syndrome revealing a neuroendocrine carcinoma of the lung].
El Bakkal A; Idrissi R; Meziane M; Mikou O; Sekal M; Belghiti H; Bennani A; Znati K; Amarti A; Karkos F; Amara B; El Biaze M; Benjelloun MC; Brahmi S; Elmesbahi O; Mernissi FZ
Ann Dermatol Venereol; 2011 Oct; 138(10):668-72. PubMed ID: 21978503
[TBL] [Abstract][Full Text] [Related]
4. Tripe palms and malignancy.
Cohen PR; Grossman ME; Almeida L; Kurzrock R
J Clin Oncol; 1989 May; 7(5):669-78. PubMed ID: 2651581
[TBL] [Abstract][Full Text] [Related]
5. Tripe palms: a cutaneous marker of internal malignancy.
Requena L; Aguilar A; Renedo G; Martín L; Piqué E; Fariña MC; Escalonilla P
J Dermatol; 1995 Jul; 22(7):492-5. PubMed ID: 7560439
[TBL] [Abstract][Full Text] [Related]
6. Tripe palms: a significant cutaneous sign of internal malignancy.
Lo WL; Wong CK
Dermatology; 1992; 185(2):151-3. PubMed ID: 1421630
[TBL] [Abstract][Full Text] [Related]
7. Hypertrophic pulmonary osteoarthropathy and tripe palms in a man with squamous cell carcinoma of the larynx and lung. Report of a case and review of cutaneous paraneoplastic syndromes associated with laryngeal and lung malignancies.
Cohen PR
Am J Clin Oncol; 1993 Jun; 16(3):268-76. PubMed ID: 8338062
[No Abstract] [Full Text] [Related]
8. [Analysis on point mutation of the CDKN2/p16 gene in lung cancer].
Su C; Ye Y; Wang D; Cao X; Li S; Shan X
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Feb; 19(1):37-40. PubMed ID: 11836684
[TBL] [Abstract][Full Text] [Related]
9. Malignant acanthosis nigricans, tripe palms and the sign of Leser-Tre'lat, a hint to the diagnosis of early stage ovarian cancer: a case report and review of the literature.
Kebria MM; Belinson J; Kim R; Mekhail TM
Gynecol Oncol; 2006 May; 101(2):353-5. PubMed ID: 16443260
[TBL] [Abstract][Full Text] [Related]
10. Development of tripe palms and soles in a patient with long pre-existing systemic mastocytosis and newly developed non-small cell lung cancer.
Bonnekoh H; Ohanyan T; Lenze D; Krause K; Maurer M; Zuberbier T; Siebenhaar F
J Eur Acad Dermatol Venereol; 2018 Apr; 32(4):e151-e153. PubMed ID: 29055165
[No Abstract] [Full Text] [Related]
11. Tripe Palms and Acanthosis Nigricans: A Clue for Diagnosis of Advanced Pancreatic Adenocarcinoma.
Barman B; Devi LP; Thakur BK; Raphael V
Indian Dermatol Online J; 2019; 10(4):453-455. PubMed ID: 31334069
[TBL] [Abstract][Full Text] [Related]
12. Malignant acanthosis nigricans and tripe palms in a patient with endometrial adenocarcinoma--a case report and review of literature.
Gorisek B; Krajnc I; Rems D; Kuhelj J
Gynecol Oncol; 1997 Jun; 65(3):539-42. PubMed ID: 9190991
[TBL] [Abstract][Full Text] [Related]
13. Tripe palms preceding squamous cell carcinoma of the lung by 11 months.
Stavrianeas NG; Katoulis AC; Neofotistou O; Stratigeas NP; Neamonitos C
Dermatology; 1999; 198(2):173-4. PubMed ID: 10325469
[No Abstract] [Full Text] [Related]
14. Analysis of promoter hypermethylation of death-associated protein kinase and p16 tumor suppressor genes in actinic keratoses and squamous cell carcinomas of the skin.
Tyler LN; Ai L; Zuo C; Fan CY; Smoller BR
Mod Pathol; 2003 Jul; 16(7):660-4. PubMed ID: 12861061
[TBL] [Abstract][Full Text] [Related]
15. Tripe palms associated with systemic mastocytosis: the role of transforming growth factor-alpha and efficacy of interferon-alfa.
Chosidow O; Bécherel PA; Piette JC; Arock M; Debré P; Francès C
Br J Dermatol; 1998 Apr; 138(4):698-703. PubMed ID: 9640384
[TBL] [Abstract][Full Text] [Related]
16. The bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression.
Vonlanthen S; Heighway J; Altermatt HJ; Gugger M; Kappeler A; Borner MM; van Lohuizen M; Betticher DC
Br J Cancer; 2001 May; 84(10):1372-6. PubMed ID: 11355949
[TBL] [Abstract][Full Text] [Related]
17. Patterns of EGFR, HER2, TP53, and KRAS mutations of p14arf expression in non-small cell lung cancers in relation to smoking history.
Mounawar M; Mukeria A; Le Calvez F; Hung RJ; Renard H; Cortot A; Bollart C; Zaridze D; Brennan P; Boffetta P; Brambilla E; Hainaut P
Cancer Res; 2007 Jun; 67(12):5667-72. PubMed ID: 17575133
[TBL] [Abstract][Full Text] [Related]
18. Chronic Obstructive Pulmonary Disease-Related Non-Small-Cell Lung Cancer Exhibits a Low Prevalence of EGFR and ALK Driver Mutations.
Lim JU; Yeo CD; Rhee CK; Kim YH; Park CK; Kim JS; Kim JW; Lee SH; Kim SJ; Yoon HK; Kim TJ; Lee KY
PLoS One; 2015; 10(11):e0142306. PubMed ID: 26555338
[TBL] [Abstract][Full Text] [Related]
19. Correlation between deletion of the CDKN2 gene and tyrosine kinase inhibitor resistance in adult Philadelphia chromosome-positive acute lymphoblastic leukemia.
Xu N; Li YL; Li X; Zhou X; Cao R; Li H; Li L; Lu ZY; Huang JX; Fan ZP; Huang F; Zhou HS; Zhang S; Liu Z; Zhu HQ; Liu QF; Liu XL
J Hematol Oncol; 2016 Apr; 9():40. PubMed ID: 27090891
[TBL] [Abstract][Full Text] [Related]
20. Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray.
Wang Y; Zhang D; Zheng W; Luo J; Bai Y; Lu Z
Cancer; 2008 Mar; 112(6):1325-36. PubMed ID: 18286531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
